Insights from 2024 ASCO® GI Annual Meeting


 

ASCO® GI 2024 Insights: "FRESCO-2 trial - Quality-Adjusted Time Without Symptoms of Disease or Toxicity Analysis of Fruquintinib + BSC Compared With Placebo + BSC in mCRC"

136 views
January 31, 2024
0 Comments
Login to view comments. Click here to Login
Videos